🇺🇸 FDA
Patent

US 6270781

Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

expired A61KA61K31/00A61K31/203

Quick answer

US patent 6270781 (Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors) held by Maxim Pharmaceuticals, Inc. expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Maxim Pharmaceuticals, Inc.
Grant date
Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/00, A61K31/203, A61K31/4045, A61K31/417